Viewing data from:

MENEST

ANDA

ESTROGENS, ESTERIFIED | A084948 | MONARCH PHARMACEUTICALS LLC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Menest (2023)

Total Spending

$711K

Total Claims

4,661

Beneficiaries

1,243

Avg Cost/Unit

$2.66

Spending Trend

$1.3M(2019)→$1.2M(2020)→$1.2M(2021)→$1.1M(2022)→$711K(2023)

YoY Change:+0.5%

5yr CAGR:+1.7%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.625MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.